Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis.
暂无分享,去创建一个
[1] L. Cantley,et al. Oncogenes and signal transduction , 1991, Cell.
[2] M. Prince,et al. Acanthosis nigricans and obesity: acquired and intrinsic defects in insulin action. , 1986, Metabolism: clinical and experimental.
[3] R. Wing,et al. Endocrine consequences of weight loss in obese, hyperandrogenic, anovulatory women. , 1994, Fertility and sterility.
[4] D. Ferriman,et al. THE INHERITANCE OF POLYCYSTIC OVARIAN DISEASE AND A POSSIBLE RELATIONSHIP TO PREMATURE BALDING , 1979, Clinical endocrinology.
[5] A. Arbor,et al. A Difference Between the Inheritance of Classical Juvenile-onset and Maturity-onset Type Diabetes of Young People , 1975, Diabetes.
[6] R. DeFronzo. The Triumvirate: β-Cell, Muscle, Liver: A Collusion Responsible for NIDDM , 1988, Diabetes.
[7] L. Zichella,et al. Biorhythms and stress in the physiopathology of reproduction , 1988 .
[8] R. Habershon. Letter: Kumidini hospital. , 1975, Lancet.
[9] Inhibitory effect of sandostatin on secretion of luteinising hormone and ovarian steroids in polycystic ovary syndrome , 1990, The Lancet.
[10] A. Motala,et al. Evaluation of WHO and NDDG criteria for impaired glucose tolerance. , 1994, Diabetes research and clinical practice.
[11] C. Mantzoros,et al. Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1997 by The Endocrine Society Leptin Concentrations in the Polycystic Ovary Syndrome* , 2022 .
[12] S. Jahanfar,et al. A twin study of polycystic ovary syndrome. , 1995, Fertility and sterility.
[13] M. White,et al. The IRS-1 signaling system. , 1994, Trends in biochemical sciences.
[14] M. Laakso,et al. How good a marker is insulin level for insulin resistance? , 1993, American journal of epidemiology.
[15] C. Kahn,et al. Antibodies that impair insulin receptor binding in an unusual diabetic syndrome with severe insulin resistance , 1975, Science.
[16] R. DeFronzo,et al. Mechanism of metformin action in obese and lean noninsulin-dependent diabetic subjects. , 1991, The Journal of clinical endocrinology and metabolism.
[17] S. Gündoğdu,et al. Can metformin reduce insulin resistance in polycystic ovary syndrome? , 1996, Fertility and sterility.
[18] J. Nestler. Sex hormone-binding globulin: a marker for hyperinsulinemia and/or insulin resistance? , 1993, The Journal of clinical endocrinology and metabolism.
[19] D. Comings,et al. A dopamine D3 receptor genotype is associated with hyperandrogenic chronic anovulation and resistant to ovulation induction with clomiphene citrate in female Hispanics. , 1995, Fertility and sterility.
[20] C. Berne,et al. Restored insulin sensitivity but persistently increased early insulin secretion after weight loss in obese women with polycystic ovary syndrome. , 1995, The Journal of clinical endocrinology and metabolism.
[21] F. Pettersson,et al. Epidemiology of secondary amenorrhea. I. Incidence and prevalence rates. , 1973, American journal of obstetrics and gynecology.
[22] H. Beck-Nielsen. Insulin resistance in skeletal muscles of patients with diabetes mellitus. , 1989, Diabetes/metabolism reviews.
[23] S. Johansson,et al. Women with polycystic ovary syndrome wedge resected in 1956 to 1965: a long-term follow-up focusing on natural history and circulating hormones. , 1992, Fertility and sterility.
[24] M. Czech. Structural and functional homologies in the receptors for insulin and the insulin-like growth factors , 1982, Cell.
[25] A N Peiris,et al. Biology of regional body fat distribution: relationship to non-insulin-dependent diabetes mellitus. , 1989, Diabetes/metabolism reviews.
[26] S. Franks,et al. Evidence for a single gene effect causing polycystic ovaries and male pattern baldness , 1993 .
[27] R. DeFronzo,et al. Glucose clamp technique: a method for quantifying insulin secretion and resistance. , 1979, The American journal of physiology.
[28] L. Kuller,et al. Coronary heart disease risk factors in women with polycystic ovary syndrome. , 1995, Arteriosclerosis, thrombosis, and vascular biology.
[29] R. DeFronzo,et al. Insulin Resistance: A Multifaceted Syndrome Responsible for NIDDM, Obesity, Hypertension, Dyslipidemia, and Atherosclerotic Cardiovascular Disease , 1991, Diabetes Care.
[30] O. Rosen,et al. Phosphorylation of the insulin receptor by a casein kinase I-like enzyme. , 1991, The Journal of biological chemistry.
[31] S. Marshall. Kinetics of insulin receptor internalization and recycling in adipocytes. Shunting of receptors to a degradative pathway by inhibitors of recycling. , 1985, The Journal of biological chemistry.
[32] W. Futterweit,et al. Gestational diabetes and neonatal macrosomia in the polycystic ovary syndrome. , 1991, The Journal of reproductive medicine.
[33] D. Ehrmann,et al. Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion. , 1995, Endocrine reviews.
[34] J. Dimartino-Nardi,et al. Decreased insulin sensitivity in prepubertal girls with premature adrenarche and acanthosis nigricans. , 1995, The Journal of clinical endocrinology and metabolism.
[35] J. Flier,et al. Clinical, Biochemical, and Ovarian Morphologic Features in Women With Acanthosis Nigricans and Masculinization , 1985, Obstetrics and gynecology.
[36] C. Kahn,et al. Increased protein kinase C activity is linked to reduced insulin receptor autophosphorylation in liver of starved rats. , 1990, The Journal of biological chemistry.
[37] R. Hoffmann,et al. Insulin sensitivity and antiandrogenic therapy in women with polycystic ovary syndrome. , 1995, Metabolism: clinical and experimental.
[38] K. Segal,et al. Profound Peripheral Insulin Resistance, Independent of Obesity, in Polycystic Ovary Syndrome , 1989, Diabetes.
[39] S. Kaplan,et al. Insulin resistance in nonobese patients with polycystic ovarian disease. , 1983, The Journal of clinical endocrinology and metabolism.
[40] G. Dailey,et al. Pancreatic beta-cell dysfunction as the primary genetic lesion in NIDDM. Evidence from studies in normal glucose-tolerant individuals with a first-degree NIDDM relative. , 1995, JAMA.
[41] W. Bremner,et al. Androgens in men--uses and abuses. , 1996, The New England journal of medicine.
[42] B. Sobel. Altered fibrinolysis and platelet function in the development of vascular complications of diabetes , 1996 .
[43] M. New,et al. HLA genotyping in family members and patients with familial polycystic ovarian disease. , 1983, The Journal of clinical endocrinology and metabolism.
[44] C. Sikes,et al. The hypothalamic-pituitary-adrenocortical axis in major depression. , 1988, Neurologic clinics.
[45] K. Birkeland,et al. Increased insulin sensitivity and fibrinolytic capacity after dietary intervention in obese women with polycystic ovary syndrome. , 1994, Metabolism: clinical and experimental.
[46] R. Taylor,et al. Abnormal Activation of Glycogen Synthesis in Fibroblasts from NIDDM Subjects: Evidence for an Abnormality Specific to Glucose Metabolism , 1993, Diabetes.
[47] J. Strauss,et al. Insulin as an effector of human ovarian and adrenal steroid metabolism. , 1991, Endocrinology and metabolism clinics of North America.
[48] N. Ling,et al. Expression of the genes encoding the insulin-like growth factors (IGF-I and II), the IGF and insulin receptors, and IGF-binding proteins-1-6 and the localization of their gene products in normal and polycystic ovary syndrome ovaries. , 1994, The Journal of clinical endocrinology and metabolism.
[49] L. Ibáñez,et al. Hyperinsulinemia in postpubertal girls with a history of premature pubarche and functional ovarian hyperandrogenism. , 1996, The Journal of clinical endocrinology and metabolism.
[50] P. Djordjević,et al. Androgen levels during sequential insulin euglycemic clamp studies in patients with polycystic ovary disease. , 1988, Journal of steroid biochemistry.
[51] I. Godsland,et al. Insulin resistance, secretion, and metabolism in users of oral contraceptives. , 1992, The Journal of clinical endocrinology and metabolism.
[52] R. Heine,et al. Induction of insulin resistance by androgens and estrogens. , 1994, The Journal of clinical endocrinology and metabolism.
[53] R. Barbieri,et al. Phosphorylation of 17 beta-hydroxysteroid dehydrogenase in BeWo choriocarcinoma cells. , 1994, American journal of obstetrics and gynecology.
[54] R. Unger. Lipotoxicity in the Pathogenesis of Obesity-Dependent NIDDM: Genetic and Clinical Implications , 1995, Diabetes.
[55] Joseph Schlessinger,et al. Signal transduction by receptors with tyrosine kinase activity , 1990, Cell.
[56] O. Rosen,et al. Increasing the cAMP content of IM-9 cells alters the phosphorylation state and protein kinase activity of the insulin receptor. , 1986, The Journal of biological chemistry.
[57] W. Pories,et al. Cellular alterations in liver, skeletal muscle, and adipose tissue responsible for insulin resistance in obesity and type II diabetes. , 1989, Diabetes/metabolism reviews.
[58] H. Mason,et al. INHIBITION OF OESTRADIOL PRODUCTION BY EPIDERMAL GROWTH FACTOR IN HUMAN GRANULOSA CELLS OF NORMAL AND POLYCYSTIC OVARIES , 1990, Clinical endocrinology.
[59] P. Björntorp,et al. Androgen treatment of middle-aged, obese men: effects on metabolism, muscle and adipose tissues. , 1992, The European journal of medicine.
[60] R. Horton,et al. Evidence for the importance of peripheral tissue events in the development of hirsutism in polycystic ovary syndrome. , 1983, The Journal of clinical endocrinology and metabolism.
[61] B. Fauser,et al. The relation between clinical manifestations of polycystic ovary syndrome and β‐cell function , 1993, Clinical endocrinology.
[62] C. Kahn,et al. Phorbol ester-induced serine phosphorylation of the insulin receptor decreases its tyrosine kinase activity. , 1988, The Journal of biological chemistry.
[63] R. Barbieri,et al. Hyperandrogenism, insulin resistance, and acanthosis nigricans syndrome: a common endocrinopathy with distinct pathophysiologic features. , 1983, American journal of obstetrics and gynecology.
[64] G Dailey,et al. Metabolic effects of metformin in non-insulin-dependent diabetes mellitus. , 1995, The New England journal of medicine.
[65] S. Yen,et al. Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1997 by The Endocrine Society Serum Leptin Levels in Women with Polycystic Ovary Syndrome: The Role of Insulin Resistance/ , 2022 .
[66] R. Kierland. Acanthosis Nigricans: An Analysis of Data in Twenty-Two Cases and A Study of its Frequency in Necropsy Material1 , 1947 .
[67] A. Dunaif,et al. Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle. A potential mechanism for insulin resistance in the polycystic ovary syndrome. , 1995, The Journal of clinical investigation.
[68] W. C. Keettel,et al. Observations on the Polycystic Ovary Syndrome , 1957 .
[69] S. Franks,et al. Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome , 1992 .
[70] M. Hull. Epidemiology of infertility and polycystic ovarian disease: endocrinological and demographic studies. , 1987, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.
[71] J. Clore,et al. Suppression of serum insulin by diazoxide reduces serum testosterone levels in obese women with polycystic ovary syndrome. , 1989, The Journal of clinical endocrinology and metabolism.
[72] A. Krolewski,et al. Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents. , 1990, Annals of internal medicine.
[73] J. Blenis,et al. Phosphatidylinositol 3-kinase activation is required for insulin stimulation of pp70 S6 kinase, DNA synthesis, and glucose transporter translocation , 1994, Molecular and cellular biology.
[74] F. Pettersson,et al. Epidemiology of secondary amenorrhea , 1974 .
[75] P. Parsons. The study of quantitative traits , 1983 .
[76] E. Lander,et al. Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results , 1995, Nature Genetics.
[77] H. Mason,et al. Modulation by insulin of follicle-stimulating hormone and luteinizing hormone actions in human granulosa cells of normal and polycystic ovaries. , 1996, The Journal of clinical endocrinology and metabolism.
[78] B. Grubb,et al. Clinical signs of androgen excess as risk factors for coronary artery disease. , 1990, Fertility and sterility.
[79] C. Kahn,et al. The syndromes of insulin resistance and acanthosis nigricans. Insulin-receptor disorders in man. , 1976, The New England journal of medicine.
[80] S. Reeders,et al. FAMILIAL POLYCYSTIC OVARIES: A GENETIC DISEASE? , 1988, Clinical endocrinology.
[81] R. Santen,et al. Episodic luteinizing hormone secretion in man. Pulse analysis, clinical interpretation, physiologic mechanisms. , 1973, The Journal of clinical investigation.
[82] Quantitative and selective fluorophore labeling of phosphoserine on peptides and proteins: characterization at the attomole level by capillary electrophoresis and laser-induced fluorescence. , 1995, Analytical biochemistry.
[83] R. Scully,et al. Familial hyperthecosis: comparison of endocrinologic and histologic findings with polycystic ovarian disease. , 1973, American journal of obstetrics and gynecology.
[84] R. Winkelmann,et al. ACANTHOSIS NIGRICANS: A STUDY OF 90 CASES , 1968, Medicine.
[85] S. Yen,et al. The effects of oral dehydroepiandrosterone on endocrine-metabolic parameters in postmenopausal women. , 1990, The Journal of clinical endocrinology and metabolism.
[86] M. Maffei,et al. Positional cloning of the mouse obese gene and its human homologue , 1994, Nature.
[87] G. Reaven,et al. Variations in insulin-stimulated glucose uptake in healthy individuals with normal glucose tolerance. , 1987, The Journal of clinical endocrinology and metabolism.
[88] S. C. Yen,et al. REVIEW ARTICLE: THE POLYCYSTIC OVARY SYNDROME , 1980 .
[89] K. Alberti,et al. Normal basal and insulin-stimulated fuel metabolism in lean women with the polycystic ovary syndrome. , 1993, The Journal of clinical endocrinology and metabolism.
[90] Jonathan A. Cooper,et al. C-kinase phosphorylates the epidermal growth factor receptor and reduces its epidermal growth factor-stimulated tyrosine protein kinase activity. , 1984, The Journal of biological chemistry.
[91] E. Krebs,et al. Role of multiple basic residues in determining the substrate specificity of cyclic AMP-dependent protein kinase. , 1977, The Journal of biological chemistry.
[92] J. Beckmann,et al. Familial hyperglycemia due to mutations in glucokinase. Definition of a subtype of diabetes mellitus. , 1993, The New England journal of medicine.
[93] R. Williamson,et al. Evidence for a single gene effect causing polycystic ovaries and male pattern baldness. , 1993, Clinical endocrinology.
[94] R. Bergman,et al. Quantification of the Relationship Between Insulin Sensitivity and β-Cell Function in Human Subjects: Evidence for a Hyperbolic Function , 1993, Diabetes.
[95] S. O’Rahilly,et al. Detection of Mutations in Insulin-Receptor Gene in NIDDM Patients by Analysis of Single-Stranded Conformation Polymorphisms , 1991, Diabetes.
[96] J. Moodley,et al. Evidence for insulin resistance in nonobese patients with polycystic ovarian disease. , 1987, The Journal of clinical endocrinology and metabolism.
[97] K. Polonsky,et al. Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1997 by The Endocrine Society Troglitazone Improves Defects in Insulin Action, Insulin Secretion, Ovarian Steroidogenesis, and Fibrinolysis in Women with Polycystic Ovary Syndr , 2022 .
[98] D L Rothman,et al. Increased glucose transport-phosphorylation and muscle glycogen synthesis after exercise training in insulin-resistant subjects. , 1996, The New England journal of medicine.
[99] D. Jakubowicz,et al. Disparate effects of insulin reduction with diltiazem on serum dehydroepiandrosterone sulfate levels in obese hypertensive men and women. , 1994, The Journal of clinical endocrinology and metabolism.
[100] H. Mason,et al. Insulin-like growth factor (IGF) I and II, IGF-binding proteins, and IGF-binding protein proteases are produced by theca and stroma of normal and polycystic human ovaries. , 1996, The Journal of clinical endocrinology and metabolism.
[101] Y. Ito,et al. A syndrome of female pseudohermaphrodism, hypergonadotropic hypogonadism, and multicystic ovaries associated with missense mutations in the gene encoding aromatase (P450arom). , 1994, The Journal of clinical endocrinology and metabolism.
[102] R. Williamson,et al. 5' polymorphism of the CYP17 gene is not associated with serum testosterone levels in women with polycystic ovaries. , 1996, The Journal of clinical endocrinology and metabolism.
[103] S. Yen,et al. 90291970 The effects of oral dehydroepiandrosterone on endocrine-metabolic parameters in postmenopausal women , 1991 .
[104] H. Mason,et al. Mechanisms of anovulation in polycystic ovary syndrome , 1997 .
[105] M. Rechler. Insulin-like growth factor binding proteins. , 1993, Vitamins and hormones.
[106] S. Taylor,et al. Absence of insulin receptor gene mutations in three insulin-resistant women with the polycystic ovary syndrome. , 1994, Metabolism: clinical and experimental.
[107] L. Poretsky. On the paradox of insulin-induced hyperandrogenism in insulin-resistant states. , 1991, Endocrine reviews.
[108] V. Toscano,et al. Insulin infusion amplifies 17 alpha-hydroxycorticosteroid intermediates response to adrenocorticotropin in hyperandrogenic women: apparent relative impairment of 17,20-lyase activity. , 1996, The Journal of clinical endocrinology and metabolism.
[109] A. Dunaif,et al. Suppression of hyperandrogenism does not improve peripheral or hepatic insulin resistance in the polycystic ovary syndrome. , 1990, The Journal of clinical endocrinology and metabolism.
[110] C. Kahn,et al. The structure of insulin receptor and its subunits. Evidence for multiple nonreduced forms and a 210,000 possible proreceptor. , 1982, The Journal of biological chemistry.
[111] Robert E. Jones,et al. Inhibition of sex hormone-binding globulin production in the human hepatoma (Hep G2) cell line by insulin and prolactin. , 1988, The Journal of clinical endocrinology and metabolism.
[112] C. Kahn,et al. Autophosphorylation within insulin receptor beta-subunits can occur as an intramolecular process. , 1991, Biochemistry.
[113] R. Roth,et al. Phosphorylation of Purified Insulin Receptor by cAMP Kinase , 1987, Diabetes.
[114] J. Treadway,et al. Transmembrane signaling by the human insulin receptor kinase. Relationship between intramolecular beta subunit trans- and cis-autophosphorylation and substrate kinase activation. , 1992, The Journal of biological chemistry.
[115] K. Polonsky,et al. Defects in beta-cell function in functional ovarian hyperandrogenism. , 1993, The Journal of clinical endocrinology and metabolism.
[116] K. Minaker,et al. Acanthosis nigricans in Obese Women with Hyperandrogenism: Characterization of an Insulin-Resistant State Distinct from the Type A and B Syndromes , 1985, Diabetes.
[117] C. Kahn,et al. Insulin action and the insulin signaling network. , 1995, Endocrine reviews.
[118] J. Givens. Familial polycystic ovarian disease. , 1988, Endocrinology and metabolism clinics of North America.
[119] C. Kahn,et al. 4PS/Insulin Receptor Substrate (IRS)-2 Is the Alternative Substrate of the Insulin Receptor in IRS-1-deficient Mice (*) , 1995, The Journal of Biological Chemistry.
[120] J. Flier,et al. Insulin resistance--mechanisms, syndromes, and implications. , 1991, The New England journal of medicine.
[121] A. Kitabchi,et al. Opposing Actions of Dehydroepiandrosterone and Testosterone on Insulin Sensitivity: In Vivo and In Vitro Studies of Hyperandrogenic Females , 1991, Diabetes.
[122] A. Dunaif,et al. The prevalence of hyperandrogenism in 109 consecutive female patients with diffuse alopecia. , 1988, Journal of the American Academy of Dermatology.
[123] R. Pasquali,et al. Insulin and C-Peptide Levels in Obese Patients with Polycystic Ovaries , 1982, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.
[124] J. Olefsky,et al. Cellular and molecular mechanisms of non-insulin dependent diabetes mellitus. , 1996, Journal of investigative medicine : the official publication of the American Federation for Clinical Research.
[125] S. Johansson,et al. Polycystic ovary syndrome and risk for myocardial infarction: Evaluated from a risk factor model based on a prospective population study of women , 1992, Acta obstetricia et gynecologica Scandinavica.
[126] R. Norman,et al. Insulin and C-Peptide Secretion in Non-Obese Patients with Polycystic Ovarian Disease , 1989, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.
[127] K. Gempel,et al. Mitochondria and Diabetes: Genetic, Biochemical, and Clinical Implications of the Cellular Energy Circuit , 1996, Diabetes.
[128] R. Rizzoli,et al. The role of dual energy X-ray absorptiometry of lumbar spine and proximal femur in the diagnosis and follow-up of osteoporosis. , 1995, The American journal of medicine.
[129] A. Dunaif,et al. The effects of experimental hyperinsulinemia on steroid secretion, ovarian [125I]insulin binding, and ovarian [125I]insulin-like growth-factor I binding in the rat. , 1988, Endocrinology.
[130] C. Berne,et al. Enhanced early insulin response to glucose in relation to insulin resistance in women with polycystic ovary syndrome and normal glucose tolerance. , 1994, The Journal of clinical endocrinology and metabolism.
[131] R. Gori. [Polycystic ovary]. , 1955, Prensa medica argentina.
[132] Serum immunoreactive leptin concentrations in women with polycystic ovary syndrome. , 1996, The Journal of clinical endocrinology and metabolism.
[133] C T Roberts,et al. Molecular and cellular aspects of the insulin-like growth factor I receptor. , 1995, Endocrine reviews.
[134] C. Ober,et al. Increased risk for polycystic ovary syndrome associated with human leukocyte antigen DQA1*0501. , 1992, American journal of obstetrics and gynecology.
[135] K. Jarnagin,et al. The human insulin receptor cDNA: The structural basis for hormone-activated transmembrane signalling , 1985, Cell.
[136] A. Dunaif. Insulin Resistance and Ovarian Hyperandrogenism , 1992 .
[137] R. Davis,et al. Signal transduction by the epidermal growth factor receptor is attenuated by a COOH-terminal domain serine phosphorylation site. , 1992, The Journal of biological chemistry.
[138] D. Johnston,et al. The relationship of insulin insensitivity to menstrual pattern in women with hyperandrogenism and polycystic ovaries , 1993, Clinical endocrinology.
[139] R. Wild. Obesity, lipids, cardiovascular risk, and androgen excess. , 1995, The American journal of medicine.
[140] J. Sturis,et al. Defects in Insulin Secretion and Action in Women With a History of Gestational Diabetes , 1995, Diabetes.
[141] C. Kahn. The molecular mechanism of insulin action. , 1985, Annual review of medicine.
[142] G. Conway,et al. Risk factors for coronary artery disease in lean and obese women with the polycystic ovary syndrome. , 1993, Clinical endocrinology.
[143] H. Häring,et al. Prevention by Protein Kinase C Inhibitors of Glucose-Induced Insulin-Receptor Tyrosine Kinase Resistance in Rat Fat Cells , 1991, Diabetes.
[144] K. Hall,et al. IGF-II binding on human lymphoid cells: demonstration of a common high affinity receptor for insulin like peptides. , 1984, Biochemical and biophysical research communications.
[145] H. Halkin,et al. Evaluation of WHO and NDDG Criteria for Impaired Glucose Tolerance: Results From Two National Samples , 1989, Diabetes.
[146] W. Miller,et al. Serine phosphorylation of human P450c17 increases 17,20-lyase activity: implications for adrenarche and the polycystic ovary syndrome. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[147] W. Wiser,et al. Familial ovarian hyperthecosis: A study of two families , 1971 .
[148] C. Kahn,et al. Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein , 1991, Nature.
[149] R. Bergman. Toward Physiological Understanding of Glucose Tolerance: Minimal-Model Approach , 1989, Diabetes.
[150] S. Lillioja,et al. Sex difference in insulin-stimulated glucose transport in rat and human adipocytes. , 1984, The American journal of physiology.
[151] Hughes Pe. Morphology and Morphogenesis of the Stein-Leventhal Ovary and of So-called “Hyperthecosis” , 1982 .
[152] J. Olefsky,et al. Evidence for a functional role of Shc proteins in mitogenic signaling induced by insulin, insulin-like growth factor-1, and epidermal growth factor. , 1994, The Journal of biological chemistry.
[153] Z. Damuni,et al. Autophosphorylation-activated protein kinase phosphorylates and inactivates protein phosphatase 2A. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[154] R. Bergman,et al. Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose. , 1981, The Journal of clinical investigation.
[155] U. Ruotsalainen,et al. Gender and Insulin Sensitivity in the Heart and in Skeletal Muscles: Studies Using Positron Emission Tomography , 1995, Diabetes.
[156] V. Duronio,et al. Insulin-like growth factor I receptor beta-subunit heterogeneity. Evidence for hybrid tetramers composed of insulin-like growth factor I and insulin receptor heterodimers. , 1989, The Journal of biological chemistry.
[157] G. Reaven,et al. Production of Inhibitor of Insulin-Receptor Tyrosine Kinase in Fibroblasts From Patient With Insulin Resistance and NIDDM , 1991, Diabetes.
[158] T. Okada,et al. Essential role of phosphatidylinositol 3-kinase in insulin-induced glucose transport and antilipolysis in rat adipocytes. Studies with a selective inhibitor wortmannin. , 1994, The Journal of biological chemistry.
[159] K. Elkind-Hirsch,et al. Hormone replacement therapy alters insulin sensitivity in young women with premature ovarian failure. , 1993, The Journal of clinical endocrinology and metabolism.
[160] P. Magnus,et al. Familial clustering in the polycystic ovarian syndrome. , 1989, Gynecologic and obstetric investigation.
[161] H. Yki-Järvinen,et al. Sex and insulin sensitivity. , 1984, Metabolism: clinical and experimental.
[162] J. Crave,et al. Effects of diet and metformin administration on sex hormone-binding globulin, androgens, and insulin in hirsute and obese women. , 1995, The Journal of clinical endocrinology and metabolism.
[163] R. Lindsay. The burden of osteoporosis: cost. , 1995, The American journal of medicine.
[164] G. Bell,et al. Mapping Diabetes-Susceptibility Genes: Lessons Learned From Search for DNA Marker for Maturity-Onset Diabetes of the Young , 1992, Diabetes.
[165] A. Dunaif,et al. Insulin administration alters gonadal steroid metabolism independent of changes in gonadotropin secretion in insulin-resistant women with the polycystic ovary syndrome. , 1989, The Journal of clinical investigation.
[166] S. Franks,et al. Polycystic ovary syndrome. , 1995, Archives of disease in childhood.
[167] R. DeFronzo,et al. Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group. , 1995, The New England journal of medicine.
[168] J. Wadsworth,et al. POLYCYSTIC OVARIES—A COMMON FINDING IN NORMAL WOMEN , 1988, The Lancet.
[169] D. Finegood,et al. Beta-cell dysfunction independent of obesity and glucose intolerance in the polycystic ovary syndrome. , 1996, The Journal of clinical endocrinology and metabolism.
[170] S. Gasic,et al. Troglitazone Inhibits Progesterone Production in Porcine Granulosa Cells* * This work was supported by a grant from the Sankyo Corporation (to R.J.U. and A.G.) and NIH Grant RO1-CA45181 (to M.N.). , 1998, Endocrinology.
[171] D. Ehrmann,et al. Detection of functional ovarian hyperandrogenism in women with androgen excess. , 1992, The New England journal of medicine.
[172] A. Dunaif,et al. Hyperandrogenic anovulation (PCOS): a unique disorder of insulin action associated with an increased risk of non-insulin-dependent diabetes mellitus. , 1995, The American journal of medicine.
[173] A. Ullrich,et al. Multisite serine phosphorylation of the insulin and IGF‐I receptors in transfected cells , 1991, FEBS letters.
[174] M. Czech,et al. Threonine 1336 of the human insulin receptor is a major target for phosphorylation by protein kinase C. , 1990, Biochemistry.
[175] K. Elkind-Hirsch,et al. Insulin resistance improves in hyperandrogenic women treated with Lupron. , 1993, Fertility and sterility.
[176] M. McCarthy,et al. Linkage and association of insulin gene VNTR regulatory polymorphism with polycystic ovary syndrome , 1997, The Lancet.
[177] A. Dunaif,et al. Differential effects of oral glucose-mediated versus intravenous hyperinsulinemia on circulating androgen levels in women. , 1993, Fertility and sterility.
[178] W. Crowley,et al. Hyperfunction of the hypothalamic-pituitary axis in women with polycystic ovarian disease: indirect evidence for partial gonadotroph desensitization. , 1988, The Journal of clinical endocrinology and metabolism.
[179] H. Lithell,et al. Tetraploidy in two sisters with the polycystic ovary syndrome , 1985, Clinical genetics.
[180] C. Berne,et al. Serum lipoprotein lipid profile in women with the polycystic ovary syndrome: relation to anthropometric, endocrine and metabolic variables , 1994, Clinical endocrinology.
[181] S. Lillioja,et al. Relationship between degree of obesity and in vivo insulin action in man. , 1985, The American journal of physiology.
[182] D. Apter,et al. Metabolic features of polycystic ovary syndrome are found in adolescent girls with hyperandrogenism. , 1995, The Journal of clinical endocrinology and metabolism.
[183] P. Björntorp,et al. Effects of short-term testosterone exposure on insulin sensitivity of muscles in female rats. , 1992, The American journal of physiology.
[184] M. Prince,et al. Insulin resistance with acanthosis nigricans: the roles of obesity and androgen excess. , 1986, Metabolism: clinical and experimental.
[185] A. Dunaif,et al. THE INDEPENDENT EFFECTS OF HYPERANDROGENAEMIA, HYPERINSULINAEMIA, AND OBESITY ON LIPID AND LIPOPROTEIN PROFILES IN WOMEN * , 1990 .
[186] K. Minaker,et al. Impaired in Vivo Insulin Clearance in Patients With Severe Target-Cell Resistance to Insulin , 1982, Diabetes.
[187] T. Mckenna,et al. Amenorrhea with cryptic hyperandrogenemia. , 1983, The Journal of clinical endocrinology and metabolism.
[188] S. Yen,et al. Inappropriate secretion of follicle-stimulating hormone and luteinizing hormone in polycystic ovarian disease. , 1970, The Journal of clinical endocrinology and metabolism.
[189] T. Bützow,et al. Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features. , 1996, The Journal of clinical endocrinology and metabolism.
[190] K. Osteen,et al. Human follicular fluid insulin concentrations. , 1985, The Journal of clinical endocrinology and metabolism.
[191] A. Dunaif,et al. The independent effects of hyperandrogenaemia, hyperinsulinaemia, and obesity on lipid and lipoprotein profiles in women. , 1990, Clinical endocrinology.
[192] M. Nagamani,et al. Hyperinsulinemia in hyperthecosis of the ovaries. , 1986, American journal of obstetrics and gynecology.
[193] L. Kuller,et al. Carotid atherosclerosis in women with polycystic ovary syndrome: initial results from a case-control study. , 1996, American journal of obstetrics and gynecology.
[194] J. Olefsky,et al. Cellular mechanisms of insulin resistance in polycystic ovarian syndrome. , 1992, The Journal of clinical endocrinology and metabolism.
[195] R. Considine,et al. Leptin: The Tale of an Obesity Gene , 1996, Diabetes.
[196] E. Goldsmith,et al. Autophosphorylation activates the soluble cytoplasmic domain of the insulin receptor in an intermolecular reaction. , 1989, The Journal of biological chemistry.
[197] F. Drew. The epidemiology of secondary amenorrhea. , 1961, Journal of chronic diseases.
[198] R. S. Spielman,et al. A genome–wide search for human non–insulin–dependent (type 2) diabetes genes reveals a major susceptibility locus on chromosome 2 , 1996, Nature Genetics.
[199] D. Rosenbaum,et al. Insulin resistance in polycystic ovary syndrome: decreased expression of GLUT-4 glucose transporters in adipocytes. , 1993, The American journal of physiology.
[200] A. Dunaif,et al. Ethnicity and Polycystic Ovary Syndrome are Associated With Independent and Additive Decreases in Insulin Action in Caribbean-Hispanic Women , 1993, Diabetes.
[201] T. Hunter,et al. Phosphopeptide mapping and phosphoamino acid analysis by two-dimensional separation on thin-layer cellulose plates. , 1991, Methods in enzymology.
[202] R. Mueller,et al. Relationship of androgenic activity to splanchnic insulin metabolism and peripheral glucose utilization in premenopausal women. , 1987, The Journal of clinical endocrinology and metabolism.
[203] P. Björntorp,et al. Mechanisms Behind Insulin Resistance in Rat Skeletal Muscle After Oophorectomy and Additional Testosterone Treatment , 1996, Diabetes.
[204] R. Norman,et al. Ethnic differences in insulin and glucose response to glucose between white and Indian women with polycystic ovary syndrome. , 1995, Fertility and sterility.
[205] N. Schork,et al. Genetic Analysis of NIDDM: The Study of Quantitative Traits , 1996, Diabetes.
[206] R. Rittmaster,et al. The role of adrenal hyperandrogenism, insulin resistance, and obesity in the pathogenesis of polycystic ovarian syndrome. , 1993, The Journal of clinical endocrinology and metabolism.
[207] P. Hughesdon. Morphology and morphogenesis of the Stein-Leventhal ovary and of so-called "hyperthecosis". , 1982, Obstetrical & gynecological survey.
[208] R A Roth,et al. Activation of protein kinase C alpha inhibits insulin-stimulated tyrosine phosphorylation of insulin receptor substrate-1. , 1994, Molecular endocrinology.
[209] J. Olefsky,et al. Insulin receptor substrate 1 is required for insulin-mediated mitogenic signal transduction. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[210] C. R. Kahn,et al. Insulin Action, Diabetogenes, and the Cause of Type II Diabetes , 1994, Diabetes.
[211] William Arbuthnot Sir Lane,et al. Role of IRS-2 in insulin and cytokine signalling , 1995, Nature.
[212] R. Shulman,et al. Decreased muscle glucose transport/phosphorylation is an early defect in the pathogenesis of non-insulin-dependent diabetes mellitus. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[213] H. Yki-Järvinen,et al. Effects of Body Composition on Insulin Sensitivity , 1983, Diabetes.
[214] R. DeFronzo. Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM. , 1988, Diabetes.
[215] M. Muggeo,et al. The insulin resistance in women with hyperandrogenism is partially reversed by antiandrogen treatment: evidence that androgens impair insulin action in women. , 1996, The Journal of clinical endocrinology and metabolism.
[216] J. Sturis,et al. Effects of metformin on insulin secretion, insulin action, and ovarian steroidogenesis in women with polycystic ovary syndrome. , 1997, The Journal of clinical endocrinology and metabolism.
[217] S. O’Rahilly,et al. Molecular scanning of the insulin receptor gene in women with polycystic ovarian syndrome. , 1996, The Journal of clinical endocrinology and metabolism.
[218] M. Maffei,et al. Positional cloning of the mouse obese gene and its human homologue , 1995, Nature.
[219] D. Finegood,et al. Polycystic ovary syndrome: lack of hypertension despite profound insulin resistance. , 1992, The Journal of clinical endocrinology and metabolism.
[220] R. Wild,et al. Lipid and apolipoprotein abnormalities in hirsute women. I. The association with insulin resistance , 1992, American journal of obstetrics and gynecology.
[221] F. Naftolin,et al. Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome. , 1976, The Journal of clinical investigation.
[222] J. Little,et al. Polycystic ovaries and premature male pattern baldness are associated with one allele of the steroid metabolism gene CYP17. , 1994, Human molecular genetics.
[223] A. Dunaif,et al. Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and/or hyperinsulinemia. , 1987, The Journal of clinical endocrinology and metabolism.
[224] J. Olefsky,et al. Cellular insulin resistance in adipocytes from obese polycystic ovary syndrome subjects involves adenosine modulation of insulin sensitivity. , 1997, The Journal of clinical endocrinology and metabolism.
[225] J. Olefsky,et al. Reversibility of defective adipocyte insulin receptor kinase activity in non-insulin-dependent diabetes mellitus. Effect of weight loss. , 1988, The Journal of clinical investigation.
[226] A. Lanzone,et al. Polycystic ovary disease. A risk factor for gestational diabetes? , 1995, The Journal of reproductive medicine.
[227] D. Finegood,et al. The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome. , 1996, The Journal of clinical endocrinology and metabolism.
[228] S. Lillioja,et al. In Vivo Insulin Action Is Familial Characteristic in Nondiabetic Pima Indians , 1987, Diabetes.
[229] H. E. Cooper,et al. Hereditary factors in the Stein-Leventhal syndrome. , 1968, American journal of obstetrics and gynecology.
[230] R. Lobo,et al. Adult manifestation of congenital adrenal hyperplasia due to incomplete 21-hydroxylase deficiency mimicking polycystic ovarian disease. , 1980, American journal of obstetrics and gynecology.
[231] N. Whitworth,et al. Effect of body weight reduction on plasma androgens in obese, infertile women. , 1982, Fertility and sterility.
[232] J. Olefsky,et al. 3 The Genetics of Non-insulin-Dependent Diabetes Mellitus , 1995 .
[233] B. Spiegelman,et al. IRS-1-Mediated Inhibition of Insulin Receptor Tyrosine Kinase Activity in TNF-α- and Obesity-Induced Insulin Resistance , 1996, Science.
[234] D. Jakubowicz,et al. Decreases in ovarian cytochrome P450c17 alpha activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome. , 1996, The New England journal of medicine.
[235] J. Caro. Clinical review 26: Insulin resistance in obese and nonobese man. , 1991, The Journal of clinical endocrinology and metabolism.
[236] M. New,et al. Insulin insensitivity in adrenal hyperplasia due to nonclassical steroid 21-hydroxylase deficiency. , 1992, The Journal of clinical endocrinology and metabolism.
[237] R. Norman,et al. Hyperinsulinemia is common in family members of women with polycystic ovary syndrome. , 1996, Fertility and sterility.
[238] T. Wagner,et al. Targeted overexpression of luteinizing hormone in transgenic mice leads to infertility, polycystic ovaries, and ovarian tumors. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[239] D. Kelley,et al. Role of reduced suppression of glucose production and diminished early insulin release in impaired glucose tolerance. , 1992, The New England journal of medicine.
[240] M. Sampson,et al. Ambulatory blood pressure profiles and plasminogen activator inhibitor (PAI‐1) activity in lean women with and without the polycystic ovary syndrome , 1996, Clinical endocrinology.
[241] A. Ullrich,et al. Intermolecular transphosphorylation between insulin receptors and EGF‐insulin receptor chimerae. , 1989, The EMBO journal.
[242] J. Witte,et al. Genetic dissection of complex traits. , 1994, Nature genetics.
[243] P. Bennett,et al. Prevalence of Diabetes and Impaired Glucose Tolerance and Plasma Glucose Levels in U.S. Population Aged 20–74 Yr , 1987, Diabetes.
[244] L. Harrison,et al. Delineation of atypical insulin receptors from classical insulin and type I insulin-like growth factor receptors in human placenta. , 1989, The Biochemical journal.
[245] J. Pessin,et al. Functional expression of insulin receptor substrate-1 is required for insulin-stimulated mitogenic signaling. , 1993, The Journal of biological chemistry.
[246] D. Koshland,et al. Protein kinase C directly phosphorylates the insulin receptor in vitro and reduces its protein-tyrosine kinase activity. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[247] H. White,et al. Association between Polycystic Ovaries and Extent of Coronary Artery Disease in Women Having Cardiac Catheterization , 1997, Annals of Internal Medicine.
[248] S. Jacobs,et al. Insulin/IGF‐I receptor hybrids: A mechanism for increasing receptor diversity , 1992, Journal of cellular biochemistry.
[249] E. Ravussin,et al. Racial differences in the relation between blood pressure and insulin resistance. , 1991, The New England journal of medicine.
[250] R. Shulman,et al. NMR studies of muscle glycogen synthesis in insulin-resistant offspring of parents with non-insulin-dependent diabetes mellitus immediately after glycogen-depleting exercise. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[251] A. Kitabchi,et al. Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease. , 1980, The Journal of clinical endocrinology and metabolism.
[252] G. Reaven,et al. Membrane glycoprotein PC-1 and insulin resistance in non-insulin-dependent diabetes mellitus , 1995, Nature.
[253] J. Goldzieher,et al. The polycystic ovary. I. Clinical and histologic features. , 1962, The Journal of clinical endocrinology and metabolism.
[254] K. Segal,et al. Evidence for Distinctive and Intrinsic Defects in Insulin Action in Polycystic Ovary Syndrome , 1992, Diabetes.
[255] M. McCarthy,et al. Association of the steroid synthesis gene CYP11a with polycystic ovary syndrome and hyperandrogenism. , 1997, Human molecular genetics.
[256] J. Skyler,et al. Insulin Action During Pregnancy: Studies with the Euglycemic Clamp Technique , 1985, Diabetes.
[257] C. Kahn,et al. Insulin stimulates the phosphorylation of the 95,000-dalton subunit of its own receptor. , 1982, Science.
[258] M. Byrne,et al. Insulin secretory defects in polycystic ovary syndrome. Relationship to insulin sensitivity and family history of non-insulin-dependent diabetes mellitus. , 1995, The Journal of clinical investigation.
[259] R. Legro,et al. Size Polymorphisms of the Androgen Receptor Among Female Hispanics and Correlation With Androgenic Characteristics , 1994, Obstetrics and gynecology.
[260] W. Wiser,et al. Hyperthecosis: an inheritable form of polycystic ovarian disease. , 1975, Birth defects original article series.
[261] M. Lebwohl,et al. Acanthosis Nigricans, insulin action, and hyperandrogenism: clinical, histological, and biochemical findings. , 1991, The Journal of clinical endocrinology and metabolism.
[262] C. Glueck,et al. Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy. , 1994, Metabolism: clinical and experimental.
[263] S. Berga,et al. Metabolic effects of oral contraceptives in women with polycystic ovary syndrome. , 1995, The Journal of clinical endocrinology and metabolism.
[264] J. Clore,et al. Suppression of serum insulin level by diazoxide does not alter serum testosterone or sex hormone-binding globulin levels in healthy, nonobese women. , 1990, American journal of obstetrics and gynecology.
[265] R. Lobo,et al. Does ethnicity influence the prevalence of adrenal hyperandrogenism and insulin resistance in polycystic ovary syndrome? , 1992, American journal of obstetrics and gynecology.
[266] E. Adashi,et al. Insulin enhancement of luteinizing hormone and follicle-stimulating hormone release by cultured pituitary cells. , 1981, Endocrinology.
[267] J. Clore,et al. Dehydroepiandrosterone reduces serum low density lipoprotein levels and body fat but does not alter insulin sensitivity in normal men. , 1988, The Journal of clinical endocrinology and metabolism.
[268] S. Franks,et al. Insulin action in human granulosa cells from normal and polycystic ovaries is mediated by the insulin receptor and not the type-I insulin-like growth factor receptor. , 1995, The Journal of clinical endocrinology and metabolism.
[269] P. H. Seeburg,et al. Human insulin receptor and its relationship to the tyrosine kinase family of oncogenes , 1985, Nature.
[270] L. Poretsky,et al. The gonadotropic function of insulin. , 1987, Endocrine reviews.
[271] D. Chapin,et al. The effects of continuous androgen secretion on the hypothalamic-pituitary axis in woman: evidence from a luteinized thecoma of the ovary. , 1984, The Journal of clinical endocrinology and metabolism.
[272] R. Wild,et al. The influence of body weight on lipoprotein lipids in patients with polycystic ovary syndrome. , 1988, American journal of obstetrics and gynecology.
[273] C. Roberts,et al. Expression of insulin-like growth factor-I (IGF-I) and IGF-II and the IGF-I, IGF-II, and insulin receptor genes and localization of the gene products in the human ovary. , 1993, The Journal of clinical endocrinology and metabolism.
[274] R. Bergman,et al. Assessment of insulin sensitivity in vivo: a critical review. , 1989, Diabetes/metabolism reviews.
[275] A. Murdoch,et al. Severe impairment of insulin action in adipocytes from amenorrheic subjects with polycystic ovary syndrome. , 1994, Metabolism: clinical and experimental.